Cowen and Company’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Cowen and Company’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-509,794	Closed	-$2.87M	–	794
2022 Q3	$2.87M	Hold	509,794	–	–	0.27%	46
2022 Q2	$2.21M	Hold	509,794	–	–	0.21%	63
2022 Q1	$5.93M	Hold	509,794	–	–	0.57%	35
2021 Q4	$9.31M	Buy	+509,794	New	+$6.47M	0.84%	26

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cowen and Company's OYST Position: Q4 2022 in Review

Cowen and Company sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 509,794 shares — an estimated $2.87M sold.

Cowen and Company first reported a position in OYST in Q4 2021 and held it in 4 quarters. The position peaked at $9.31M in Q4 2021. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

Cowen and Company reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cowen and Company sold 509,794 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $2.87M.
Cowen and Company first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Cowen and Company's Oyster Point Pharma, Inc. Common Stock position peaked at $9.31M in Q4 2021.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.